血管紧张素II抑制与心房颤动及中风的预防 - Suppr | 超能文献

Angiotensin II inhibition and prevention of atrial fibrillation and stroke.

作者信息

Bourassa Martial G

出版信息

J Am Coll Cardiol. 2005 Mar 1;45(5):720-1. doi: 10.1016/j.jacc.2004.12.008.

DOI:10.1016/j.jacc.2004.12.008

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Angiotensin II inhibition and prevention of atrial fibrillation and stroke.血管紧张素II抑制与心房颤动及中风的预防

J Am Coll Cardiol. 2005 Mar 1;45(5):720-1. doi: 10.1016/j.jacc.2004.12.008.

2

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.与阿替洛尔相比，血管紧张素II受体阻滞剂可降低新发房颤及后续卒中风险：氯沙坦干预降低高血压终点事件研究（LIFE研究）。

J Am Coll Cardiol. 2005 Mar 1;45(5):712-9. doi: 10.1016/j.jacc.2004.10.068.

3

Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.有房颤病史的高血压患者的心血管发病率和死亡率：氯沙坦干预降低高血压终点事件（LIFE）研究

J Am Coll Cardiol. 2005 Mar 1;45(5):705-11. doi: 10.1016/j.jacc.2004.06.080.

4

Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.在氯沙坦干预降低高血压终点事件（LIFE）研究中，氯沙坦对中风有益的潜在机制。

Curr Med Res Opin. 2007 Feb;23(2):443-57. doi: 10.1185/030079906X167435.

5

[Fewer cases of stroke, atrial fibrillation, diabetes and renal insufficiency. Good treatment of hypertension is more than lowering of blood pressure].中风、心房颤动、糖尿病和肾功能不全的病例减少。良好的高血压治疗不仅仅是降低血压。

MMW Fortschr Med. 2008 Jan 17;150(1-2):52-3.

6

Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.高血压患者心房颤动发生率与心率随时间变化的关系：LIFE研究

Circ Arrhythm Electrophysiol. 2008 Dec;1(5):337-43. doi: 10.1161/CIRCEP.108.795351. Epub 2008 Dec 2.

7

[Therapy of hypertension in patients with atrial fibrillation. Sartan is superior to beta-blocker].[心房颤动患者的高血压治疗。沙坦类药物优于β受体阻滞剂]

MMW Fortschr Med. 2003 May 8;145(19):53.

8

Can losartan prevent new-onset atrial fibrillation in hypertensive patients more effectively than atenolol?

Nat Clin Pract Cardiovasc Med. 2005 Jul;2(7):332-3. doi: 10.1038/ncpcardio0247.

9

[LIFE study proves preventive action. With losartan to do even more against stroke].

MMW Fortschr Med. 2003;145 Suppl 1:7-8.

10

Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.高血压左心室肥厚患者氯沙坦干预降低终点事件（LIFE）研究中的血压降低及降压药物使用情况

Curr Med Res Opin. 2007 Feb;23(2):259-70. doi: 10.1185/030079906X162854.

引用本文的文献

1

Industry pulse : editorial development by adis international limited, Italy.

High Blood Press Cardiovasc Prev. 2005 Sep;12(3):195-8. doi: 10.2165/00151642-200512030-00174.

2

QRS duration is associated with atrial fibrillation in patients with left ventricular dysfunction.QRS 时限与左心功能障碍患者的心房颤动有关。

Clin Cardiol. 2010 Mar;33(3):132-8. doi: 10.1002/clc.20714.

3

Rate versus rhythm control strategies for AF.

Curr Treat Options Cardiovasc Med. 2005 Oct;7(5):371-81. doi: 10.1007/s11936-005-0021-3.